How Much Does Lymphoma chemotherapy Cost in Republic of Korea?
Lymphoma chemotherapy in the Republic of Korea typically costs from $9,000 to $16,000. Total expenses depend on the lymphoma stage, specific drug protocols, and hospital choice. Patients save around 61% compared to the US, where this treatment costs $32,000 on average. Inclusions generally cover initial diagnostics, chemotherapy administration, and standard oncology consultations in medical hubs like Seoul and Goyang.
- Advanced therapies: Targeted drugs and monoclonal antibodies typically increase costs by 20-30%.
- Bone marrow transplant: Procedures for complex cases often start around 15-20% above standard chemo.
- International patient cycles: Basic introductory chemotherapy cycles usually start around a few thousand dollars.
- Hospital tier differences: Premium centers in Seoul may cost more than regional facilities like Goyang.
Bookimed Expert Insight: Choosing Seoul for oncology provides access to massive-scale centers like Severance Hospital. This facility founded in 1885 is JCI-accredited and performs 4,000,000 annual patient visits. Samsung Medical Center also offers high-value care as Asia's largest cancer center. It partners with the Mayo Clinic and uses advanced proton beam therapy. These clinics provide presidential-standard care at roughly $4,000 to $10,100 per cycle. This price point delivers world-class technology for a fraction of US costs.
| Republic of Korea | Turkey | Austria | |
|---|---|---|---|
| Lymphoma chemotherapy | ≈ $9,000 | from $3,300 | ≈ $8,000 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Lymphoma chemotherapy upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphoma chemotherapy and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphoma chemotherapy journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Discover the Best Lymphoma chemotherapy Clinics in Republic of Korea: 3 Verified Options and Prices
Lymphoma chemotherapy Overview in Republic of Korea
- Chemotherapy - from $1,900This therapy treats cancer by using drugs to destroy cancer cells and prevent their growth.
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - from $18,000The operation heats chemotherapy drugs and applies them directly inside the belly to kill hidden cancer cells.
- Chemotherapy for liver cancer - from $3,000This therapy targets and kills cancer cells in the liver, using drugs given by mouth or injection.
- Chemotherapy for lung cancer - from $1,500This therapy utilizes drugs to kill lung cancer cells, often given via injection or oral tablet, enhancing survival rates.
- Chemotherapy for breast cancer - from $3,000This therapy targets and destroys breast cancer cells, using powerful drugs, enhancing survival and recovery rates.
Day 1
- Arrival at the airport.
- Transfer from the airport to the hotel.
Day 2
- Transfer from the hotel to the clinic.
- Consultation with the oncologist and hematologist.
- Blood tests and imaging scans are performed.
Day 3-4
- Preparation for chemotherapy.
- Chemotherapy session, which lasts from 2 to 6 hours.
- No anesthesia is required for chemotherapy.
Day 5
- Assessment of the response to chemotherapy.
- Transfer back to the hotel.
Week 2-6
- Chemotherapy is typically repeated every 2 to 3 weeks.
- Regular blood tests to monitor your condition.
Week 7 onwards
- Gradual return to normal activities as strength returns.
- Full recovery may take several months.
Please note that the above timeline is a general guideline and individual cases may vary.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Doctors
View all Doctors
Cho Byung Chul
The doctor is the Head of the Oncology Department, specializing in chemotherapy for lung cancer, head and neck cancer, and esophageal cancer. The focus is on utilizing new clinical drugs to improve treatment outcomes. With extensive experience in oncological therapies, the doctor is at the forefront of cancer treatment advancements.

Keun Chil Park
Dr. Keun Chil Park leads the Division of Hematology-Oncology at Samsung Medical Center in Seoul. He specializes in treating lung, esophageal, and head and neck cancers. Dr. Park earned his medical degree from Seoul National University College of Medicine.
- Member of the American Society of Clinical Oncology (ASCO).
- Member of the European Society of Medical Oncology (ESMO).
- Affiliated with the International Association for the Study of Lung Cancer.
- Works at a hospital ranked among the world’s best by Newsweek.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about Lymphoma chemotherapy in Republic of Korea
What are the survival rates for lymphoma treated with chemotherapy in South Korea?
South Korea reports high survival rates for lymphoma, with a general 72.9% 5-year relative survival across all cancers. Specific subtypes like MALT lymphoma reach 98.6% survival. Outcomes for Diffuse Large B-cell Lymphoma (DLBCL) improved to over 61% following the adoption of R-CHOP chemotherapy protocols.
- Subtype variations: MALT lymphoma survival exceeds 97% over 10 years with modern chemotherapy.
- Treatment impact: Adding rituximab to standard CHOP regimens increased DLBCL survival by 12%.
- Advanced therapies: Combining chemotherapy with stem cell transplantation boosts T-cell lymphoma survival to 57.8%.
- Early-stage outcomes: Early detection of Hodgkin lymphoma results in survival rates reaching up to 95%.
Bookimed Expert Insight: High patient volumes at Seoul centers correlate with superior survival outcomes. Severance Hospital and Samsung Medical Center treat over 6 million patients combined annually. This massive scale allows oncologists to refine R-CHOP and ABVD protocols, maintaining success rates that rival or exceed global benchmarks.
Patient Consensus: Patients emphasize that early diagnosis at major Seoul hospitals leads to 80-90% survival. Many note that Korea's efficient, tech-driven medical system ensures no missed chemotherapy cycles.
Which hospitals are considered primary centers for lymphoma chemotherapy in South Korea?
South Korea’s primary centers for lymphoma chemotherapy include the Big 5 university hospitals in Seoul, led by Samsung Medical Center and Asan Medical Center. These JCI-accredited facilities integrate advanced hematologic Malignancy Centers, offering specialized R-CHOP protocols and stem cell transplantation for aggressive subtypes.
- Samsung Medical Center: Ranked 1st in Asia-Pacific oncology, serving over 2,000,000 patients annually with presidential standards.
- Asan Medical Center: South Korea's largest multidisciplinary hospital, globally recognized for high-volume complex hematologic case management.
- Severance Hospital: A JCI-certified pioneer featuring a dedicated patient navigator system specifically for international oncology.
- Seoul National University: Operates a specialized Hematologic Malignancy Center focused on precision chemotherapy and clinical trials.
Bookimed Expert Insight: While all Big 5 hospitals offer elite care, Severance Hospital stands out for international logistics. Their patient navigator system manages the complex scheduling required for multi-cycle chemotherapy. This significantly reduces the administrative burden for patients traveling from abroad compared to larger, higher-volume public centers.
Patient Consensus: Patients emphasize the efficiency of the international clinics, noting that having translated medical records ready significantly accelerates treatment planning. Many also highlight the seamless transition from intensive chemotherapy to stem cell transplants at Asan Medical Center.
Are advanced therapies such as CAR-T cell therapy or heavy ion therapy available for lymphoma in South Korea?
South Korea provides advanced CAR-T cell therapy and heavy ion therapy for lymphoma. Major Seoul-based hospitals like Samsung Medical Center and Severance Hospital utilize these precision treatments for relapsed diffuse large B-cell lymphoma. These facilities hold Joint Commission International and KOIHA accreditations.
- CAR-T availability: Available at Samsung Medical Center for relapsed or refractory lymphoma.
- Heavy ion centers: Severance Hospital (Yonsei) launched the first operational carbon-ion facility.
- Clinical certifications: Top facilities maintain Newsweek-ranked status and ISO international quality standards.
- Treatment hubs: Procedures concentrate in Seoul at high-volume clinics with 1,400+ doctors.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital represent the highest concentration of specialized cancer technology in Korea. While Severance leads in heavy ion therapy, Samsung serves over 2 million patients annually. Their high volume translates to significant experience with complex hematologic cases. Patients should prioritize these Seoul-based giants for the newest treatment protocols.
Patient Consensus: Patients report that while revolutionary therapies are domestically available, waitlists at major Seoul hospitals are often long. Many advise getting multiple assessments at different clinics to clarify immediate therapy options.
What documentation is required for international patients to receive chemotherapy for lymphoma in South Korea?
International patients must provide a medical visa (C-3-3 or G-1-10), an official hospital invitation, and a doctor's letter confirming the treatment plan. Essential clinical documentation includes English-translated pathology reports, biopsy slides for local re-verification, and recent PET or CT scans from specialized oncology centers.
- Visa documentation: Provide a valid passport and hospital business registration for medical visa applications.
- Financial verification: Submit stamped bank statements showing at least $10,000 to cover chemotherapy cycles.
- Clinical records: Include detailed pathology reports and original biopsy slides for mandatory Korean lab re-testing.
- Legal requirements: Assign an English-speaking guardian or official translator for signing medical consent forms.
Bookimed Expert Insight: Data from top-tier institutions like Severance Hospital and Samsung Medical Center shows they prioritize patients who submit pathology results 2 months early. Since these JCI-accredited centers often require local re-verification of slides, early digital submission secures treatment slots faster and prevents diagnostic delays upon arrival in Seoul.
Patient Consensus: Patients emphasize bringing physical biopsy slides rather than just digital reports, as Korean specialists frequently conduct their own lab analysis. Having cash reserves for upfront payments is also recommended to streamline the initial admission process.















